BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ: BLSM · Real-Time Price · USD

13.94

-1.04 (-6.94%)

Oct 16, 2026, 4:00 PM EDT - Market closed

BlossomHill Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	443	-	-
Market Cap Growth	-	-	-
Enterprise Value	371	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.28	0.18	0.01
Net Debt / Equity Ratio	-0.88	-0.91	-1.00
Net Debt / EBITDA Ratio	0.85	1.80	2.76
Net Debt / FCF Ratio	1.01	2.38	3.16
Quick Ratio	5.12	8.83	14.79
Current Ratio	5.42	8.97	15.38
Return on Equity (ROE)	-	-53.80%	-
Return on Assets (ROA)	-	-29.67%	-
Return on Capital Employed (ROCE)	-80.80%	-43.40%	-36.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-6.47%	-

SEC Filings: 10-K · 10-Q